- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05322382
Accuracy of Pulse Oximeters With Profound Hypoxia
April 11, 2022 updated by: CardiacSense Ltd.
Accuracy of Pulse Oximeters With Profound Hypoxia - Test Protocol
This project aims to test the accuracy of pulse oximeters during mild, moderate, and severe hypoxia, i.e., a range of arterial HbO2 saturation from 100 down to 70%.
A typical study will include at least ten subjects (at least 200 necessary data points to meet the ISO 80601-2-61:2017).
Study Overview
Detailed Description
After local anesthetic injection, a 22-gauge catheter is inserted in one radial artery.
Pulse oximeters are attached to fingers, ears, or flat body surfaces.
Subjects are in a comfortable semi-recumbent position.
Subjects then breathe air mixtures containing reduced amounts of oxygen to produce the desired level of hypoxemia.
Stable, safe, and controlled hypoxia is breath-by-breath by breath respiratory gas analysis and a computer program that permits the inspired gas mixture to be adjusted to achieve a level of lung alveolar gas that will achieve the desired degree of saturation.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California at San Francisco
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subject is male or female, aged ≥18 and <50.
- The subject is in good general health with no evidence of any medical problems.
- The subject is fluent in both written and spoken English.
- The subject has provided informed consent and is willing to comply with the study procedures.
Exclusion Criteria:
- The subject is obese (BMI>30).
- The subject has a known history of heart disease, lung disease, kidney or liver disease.
- Diagnosis of asthma, sleep apnea, or use of CPAP.
- Subject has diabetes.
- Subject has a clotting disorder.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Single
Subjects undergo an interventional procedure and non-invasive measurements of SpO2.
|
Subjects breathe air mixtures containing reduced amounts of oxygen to produce the desired level of hypoxemia.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Accuracy of pulse oximeter with profound hypoxia
Time Frame: 2 days
|
Perform accurate measurement of a range of arterial HbO2 saturation from 100 to down to 70% during mild, moderate, and severe hypoxia.
|
2 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Philip Bickler, MD, UCSF Hypoxia Lab
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 2, 2021
Primary Completion (Actual)
June 3, 2021
Study Completion (Actual)
June 3, 2021
Study Registration Dates
First Submitted
April 4, 2022
First Submitted That Met QC Criteria
April 4, 2022
First Posted (Actual)
April 11, 2022
Study Record Updates
Last Update Posted (Actual)
April 18, 2022
Last Update Submitted That Met QC Criteria
April 11, 2022
Last Verified
April 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 008_SPO_CV_OS_USF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on SpO2
-
GE HealthcareNot yet recruitingSpO2 | SpO2 (Peripheral Oxygen Saturation) Measurement ValidationUnited States
-
Czech Technical University in PragueCompletedMovement Artifacts During SpO2 Measurements | Reduced Perfusion During SpO2 MeasurementsCzechia
-
Philips Clinical & Medical Affairs GlobalCompletedSpO2 (Peripheral Oxygen Saturation) Measurement ValidationUnited States
-
Masimo CorporationRecruiting
-
Masimo CorporationCompleted
-
National Taiwan University HospitalRecruiting
-
Masimo CorporationCompletedEvaluation of SpO2 PerformanceUnited States
-
Masimo CorporationCompletedEvaluation of SpO2 PerformanceUnited States
-
Philips Clinical & Medical Affairs GlobalTerminated
Clinical Trials on A-line
-
Johns Hopkins UniversityTerminatedAtaxia-Telangiectasia (A-T)United States
-
Centre Chirurgical Marie LannelongueNot yet recruiting
-
Technical University of MunichRecruitingCastration-resistant Prostate CancerGermany
-
Jamil Cedeño MoraHospital General Universitario Gregorio Marañon; Fundación para la Investigación...Recruiting
-
Northern TherapeuticsUnity Health Toronto; Sir Mortimer B. Davis - Jewish General HospitalCompleted
-
University Hospital, GhentUniversity GhentEnrolling by invitationQuality of Life | Constipation | Sleep Quality | Adverse Childhood Experiences | Lower Urinary Tract Symptoms (LUTS) | Genitourinary Issues | Transition Care | Enuresis NocturnalBelgium
-
Memorial Sloan Kettering Cancer CenterCompletedMelanomaUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); National Institutes of Health (NIH)Enrolling by invitationSmoking | Smoking Cessation | Tobacco UseUnited States
-
Ciusss de L'Est de l'Île de MontréalFonds de la Recherche en Santé du Québec; Fondation Anesthesiologistes du QuebecNot yet recruitingAnesthesia | Perioperative Care | Hemodynamics | Vasopressor | Fluid Management | Monitoring Blood Pressure | Artificial Intelligence in Operating Room | Arterial Lines | Artificial Intelligence (AI)Canada